Clinical Trials

You are here:

Home
Clinical Trials

Register for Clinical Trials authorized since 2016- Updated on 3rd Feb 2025

entries per page

Search:

SN	CTA #	Title	Date of initial Authorization	Principal Investigator	Institution	Sponsor	Status	Duration of the trial
1.	0001	Malaria Chemoprevention with monthly treatment with dihydroartemisinin-piperaquine for the post-discharge management of severe anemia in children aged less than 5 years in Uganda and Kenya: A 3-year, multi-center, parallel-group, two arm randomized placebo controlled superiority trial.	04/04/2016	Assoc Prof. Robert Opoka Opoka	Department of Pediatrics and Child Health, MUCHS	Liverpool School of Tropical Medicine (LSTM)	Closed Out
2.	0002	Doxycycline for the treatment of nodding syndrome: A phase II, randomized placebo controlled trial.	05/04/2016	Assoc Prof. Richard Idro	Department of Pediatrics and Child Health, MUCHS		Ongoing
3.	0003	Phase I/II, Multi-Center, Open-Label Pharmacokinetic, Safety, Tolerability, and Anti-Retroviral Activity of GSK 1349572 (Dolutegravir), a Novel Integrase Inhibitor, in Combination Regimens in HIV-1 Infected Infants, Children and Adolescents. (IMPAACT P1093)	19/05/2016	Dr. Maxensia Owor	Makerere University – John Hopkins University (MUJHU) Care Ltd.	United States National Institute of Health	Ongoing
4.	0004	Prevention of Malaria in HIV-uninfected Pregnant Women and Infants (PROMOTE Birth Cohort 3)	09/08/2016	Prof. Moses Kamya	MU-UCSF		Closed Out
5.	0005	A Phase 3, Randomized, Open Label Study to Evaluate the Safety and Efficacy of Switching to a Fixed Dose Combination (FDC) of GS -9883/ Emtricitabine/Tenofovir Alafenamide (GS - 9883/F/TAF) from Elvitegravir /Cobicistat /Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF), Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate (E/C/F/TDF), or Atazanavir + Ritonavir + Emtricitabine/Tenofovir Disoproxil Fumerate (ATV+RTV+FTC/TDF) in Virologically Suppressed HIV-1 Infected Women.	11/05/2016	Dr. Cissy Kityo Mutuluza	Joint Clinical Research Centre	Gilead Sciences	Ongoing
6.	0006	A randomized trial of dolutegravir (DTG)-based antiretroviral therapy vs standard of care (SOC) in children with HIV infection starting first line or switching to second line ART. (ODYSSEY PENTA 20)	15/07/2016	Dr. Cissy Kityo Mutuluza	Joint Clinical Research Centre		Closed out
7.	0007	Pharmacokinetics of efavirenz 400 mg once daily during pregnancy in HIV -1 infected women.	07/07/2016	Prof.Mohammed Lamorde	Infectious Diseases Institute		Closed out
8.	0008	Investigation of rheumatic AF Treatment Using Vitamin K antagonists, rivaroxaban or aspirin Studies. (INVICTUS)	12/12/2016	Dr. Emmy Okello	Uganda Heart Institute	Population Health Research Institute	Closed-out
9.	0009	A Multi-center, Phase 3B Open-label Follow-up trial to assess the continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women. (MTN 025)	05/09/2016	Dr. Brenda Gati Mirembe	Makerere University – John Hopkins University (MUJHU) R Care Ltd.	Division of AIDS(DAIDS), United States (US) National Institute of Allergy and Infectious Diseases (NIAID), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), US National Institute of Health (NIH)	Closed out
10.	0010	A Multi-country, prospective, clinical safety study of subjects exposed to the candidate Ebola vaccines Ad26.ZEBOV and/or MVA –BN-Filo.	02/09/2016	Prof. Pontiano Kaleebu	The Medical Research Council/Uganda Virus Research Institute (MRC/UVRI)	Janssen Vaccine	Ongoing

Showing 1 to 10 of 278 entries

Abbreviation

MUCHS	Makerere University College of Health Sciences
MU-JHU	Makerere University – John Hopkins University
MU-UCSF	Makerere University – University of California, San Francisco
MRC/UVRI	Medical Research Council / Uganda Virus Research Institute
UVRI-IAVI	Uganda Virus Research Institute – International AIDS Vaccine Initiative
LSHTM	London School of Hygiene and Tropical Medicine
MUST	Mbarara University of Science and Technology
MUWRP	Makerere University Walter Reed Project
CWRURC	Case Western Reserve University Research Collaboration
IDI	Infectious Disease Research Collaboration
MOH	Ministry of Health Uganda
NIAID	National Institute of Allergy and Infectious Diseases
NIH	National Institute of Health
MAKRIF	Makerere University Research Innovation Fund
UCI	Uganda Cancer Institute